Being diagnosed with macular degeneration often comes with a difficult message:
“Progression can be slowed, but lost central vision cannot be restored.”
For many individuals, this can create a quiet sense that further decline is simply a matter of time.
Conventional treatment typically focuses on:
However, emerging laboratory investigations suggest there may be an upstream biological regulator influencing how efficiently retinal tissue repairs itself over time.
Researchers studying aging eye tissue have identified increasing concentrations of a retinal-exclusive protein known as Prox-1.
Preliminary imaging suggests that elevated Prox-1 levels may correlate with reduced activation of adult stem cells naturally present in retinal tissue.
If validated further, this mechanism may help explain: